###begin article-title 0
###xml 46 62 46 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 46 62 <span type="species:ncbi:562">Escherichia coli</span>
Transcriptional effects of CRP* expression in Escherichia coli
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp</italic>
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 580 588 580 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
###xml 324 331 <span type="species:ncbi:562">E. coli</span>
###xml 580 587 <span type="species:ncbi:562">E. coli</span>
Escherichia coli exhibits diauxic growth in sugar mixtures due to CRP-mediated catabolite repression and inducer exclusion related to phosphotransferase system enzyme activity. Replacement of the native crp gene with a catabolite repression mutant (referred to as crp*) enables co-utilization of glucose and other sugars in E. coli. While previous studies have examined the effects of expressing CRP* mutants on the expression of specific catabolic genes, little is known about the global transcriptional effects of CRP* expression. In this study, we compare the transcriptome of E. coli W3110 (expressing wild-type CRP) to that of mutant strain PC05 (expressing CRP*) in the presence and absence of glucose.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
The glucose effect is significantly suppressed in strain PC05 relative to strain W3110. The expression levels of glucose-sensitive genes are generally not altered by glucose to the same extent in strain PCO5 as compared to W3110. Only 23 of the 80 genes showing significant differential expression in the presence of glucose for strain PC05 are present among the 418 genes believed to be directly regulated by CRP. Genes involved in central carbon metabolism (including several TCA cycle genes) and amino acid biosynthesis, as well as genes encoding nutrient transport systems are among those whose transcript levels are most significantly affected by CRP* expression.
###end p 5
###begin p 6
###xml 366 368 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
We present a detailed transcription analysis and relate these results to phenotypic differences between strains expressing wild-type CRP and CRP*. Notably, CRP* expression in the presence of glucose results in an elevated intracellular NADPH concentration and reduced NADH concentration relative to wild-type CRP. Meanwhile, a more drastic decrease in the NADPH/NADP+ ratio is observed for the case of CRP* expression in strains engineered to reduce xylose to xylitol via a heterologously expressed, NADPH-dependent xylose reductase. Altered expression levels of transhydrogenase and TCA cycle genes, among others, are consistent with these observations.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp* </italic>
While the simplest model of CRP*-mediated gene expression assumes insensitivity to glucose (or cAMP), our results show that gene expression in the context of CRP* is very different from that of wild-type in the absence of glucose, and is influenced by the presence of glucose. Most of the transcription changes in response to CRP* expression are difficult to interpret in terms of possible systematic effects on metabolism. Elevated NADPH availability resulting from CRP* expression suggests potential biocatalytic applications of crp* strains that extend beyond relief of catabolite repression.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 611 612 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli growing in a mixture of sugars exhibits diauxic growth characteristics, whereby glucose is preferentially assimilated before other sugars. This is due to CRP-mediated catabolite repression and inducer exclusion related to phosphotransferase system enzyme activity. It is well established that cyclic AMP (cAMP) and its receptor protein (CRP) are involved in transcriptional activation of catabolic genes [1,2], but the details of catabolite repression and inducer exclusion mechanisms and their relation to the levels of cAMP and CRP (also known as CAP) are not clear and have motivated many studies [3-7].
###end p 10
###begin p 11
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc</sup>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 323 327 323 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
Inducer exclusion is a result of dephosphorylation of enzyme IIAGlc of PTS [8,9] and catabolite repression is associated with altered levels of cAMP [10-12] and CRP [13]. Enzyme IIAGlc, when unphosphorylated, inhibits activity of other transport systems (non-PTS transporter) [14-16]. In its phosphorylated form, enzyme IIAGlc stimulates adenylate cyclase activity, resulting in higher intracellular levels of cAMP [17,18] and the cAMP-CRP complex (global transcription activator).
###end p 11
###begin p 12
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp* </italic>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp* </italic>
###xml 594 596 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 640 648 640 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 831 835 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 640 647 <span type="species:ncbi:562">E. coli</span>
Efforts to study or alleviate catabolite repression mediated by CRP have resulted in a series of CRP mutants isolated from strains lacking adenylate cyclase and having an apparent reduced dependence on cAMP for activating catabolic genes (called CRP*, CRP-in or CAPc) [1,19,20]. Genetically different crp* strains reported are also phenotypically different, showing different sensitivities to cyclic nucleotides and relieving catabolic repression of select genes examined to different extents [21]. For example, six different crp* mutants isolated after UV treatment and selection for a lactose+ phenotype in an adenylate cyclase-deficient E. coli strain showed a variety of utilization patterns for different sugars (lactose, maltose, arabinose, xylose, ribose, mannose, mannitol) as well as different levels of activation of the lac operon by cAMP or cGMP [22]. Similar examples have been reported by others [3,21].
###end p 12
###begin p 13
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 206 214 206 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 206 213 <span type="species:ncbi:562">E. coli</span>
Ability to co-utilize sugars via relief of catabolite repression during microbial production of value-added chemicals has potential to improve bioproduction process economics [23]. We previously engineered E. coli to produce xylitol from xylose while metabolizing glucose as a source of carbon and energy (xylose metabolism is disabled) [24,25]. Expression of CRP* was an effective approach to promote expression of xylose transporters and enhance xylitol production in the presence of glucose. Although plasmid-based, CRP-independent expression of xylose transporters in wild-type crp strains also enhances xylose uptake and xylitol production in the presence of glucose [25], the favorable effects of CRP* expression were found to go beyond improving xylose transport and to include other beneficial phenotypes such as improved xylitol titer in controlled batch fermentation and reduced acetate production and higher yields on xylose reduced per mole of glucose consumed in resting cell transformations [26].
###end p 13
###begin p 14
###xml 330 338 330 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 330 337 <span type="species:ncbi:562">E. coli</span>
While CRP*s have been studied at the molecular level and the effects of expressing CRP* mutants on the expression of specific catabolic genes have been reported, the global transcriptional effects and regulatory consequences of CRP* expression is not known. Here, we report the results of comparisons between the transcriptome of E. coli W3110 (expressing wild-type CRP) and that of mutant strain PC05 (expressing CRP*) in the presence and absence of glucose through microarray analysis. Our results show that gene expression in PC05 is drastically different from that of W3110 in both the presence and absence of glucose, and that while expression of the CRP* allele used in this study has the general effect of suppressing transcriptional changes due to glucose, a significant response to glucose nonetheless remains. Results are analyzed in light of the observed differences between wild-type and CRP* strains during xylitol production. We identify many genes showing differential expression that are consistent with the observed elevated levels of glucose oxidation and NADPH-dependent xylose reduction for PC05 compared to W3110. A subsequent intracellular cofactor analysis reveals CRP*-correlated effects on cofactor levels that are consistent with the observed expression changes.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 836 839 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp</italic>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 4 11 <span type="species:ncbi:562">E. coli</span>
###xml 79 86 <span type="species:ncbi:562">E. coli</span>
The E. coli W3110-derivative CRP* strains used in our studies are derived from E. coli donor strain ET25 [8], which expresses a CRP* mutant with three amino acid substitutions (I112L, T127I, and A144T) identical to those found in an earlier characterized CRP* strain CA8404 [1]. Amino acid position 127 lies in the cAMP binding pocket, and T127I or T127L mutations occur frequently in CRP* alleles [21,27], presumably serving to reduce the cAMP requirement to form an activating CRP complex [27]. Mutation A144T is also frequently found in different CRP* alleles [3,21,28] and can exhibit the CRP* phenotype to some extent even as the only mutation in the protein [29]. This position lies in the DNA binding domain of CRP and is suggested to improve affinity of the protein for CRP binding sites [29]. A fourth base substitution in the crp* sequence results in a T28K mutation, which is the result of native differences in the crp sequence between W3110 and the donor strain.
###end p 16
###begin title 17
Genome-wide transcriptional effects of glucose and CRP*
###end title 17
###begin p 18
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 313 321 313 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 765 766 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1072 1080 1072 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1115 1116 1115 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1534 1539 1534 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aceA </italic>
###xml 1567 1572 1567 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aldA </italic>
###xml 1600 1605 1600 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sdhA </italic>
###xml 1635 1640 1635 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sucA </italic>
###xml 1883 1888 1883 1888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aceE </italic>
###xml 1927 1932 1927 1932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">guaB </italic>
###xml 1953 1958 1953 1958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpsQ </italic>
###xml 2063 2065 2063 2065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2066 2068 2066 2068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2069 2071 2069 2071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 313 325 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 1072 1084 <span type="species:ncbi:83333">E. coli K-12</span>
Table 1 summarizes the genome-wide effects of CRP* expression under the conditions tested, while Table 2 lists the average signal values and expression ratios for specific genes mentioned in this paper. Supplementary Table S1 (see Additional file 1) contains signal values for the complete probe set data for the E. coli K-12 genome. Transcriptome analysis of strain W3110 reveals that 629 genes show significant changes in expression level in response to the presence of glucose (comparison between WT G and WT in Figure 1a). 375 of these genes are upregulated by glucose, as depicted in Figure 1a. The complete list of expression levels of the genes that are differentially expressed between WT G and WT is provided in Supplementary Table S2 (see Additional file 2). Catabolic genes, membrane-related components, and sugar transporters (especially non-glucose PTS related enzymes) represent a large portion of genes repressed by glucose. In a study of CRP-dependent gene expression, Gosset and coworkers reported transcriptome analysis of CRP-dependent genes in another E. coli K-12 strain BW25113 [30]. In Table 3 we compare their result to results from our study for common conditions tested (i.e., WT G/WT). While their study did not examine CRP*, this comparison provides an indication of the consistency of glucose-responsive gene expression among different but similar strains. Our comparison focuses on genes involved in central metabolism and shows that the genes which are subject to glucose repression in BW25113 (such as aceA (isocitrate lyase monomer), aldA (aldehyde dehydrogenase A), sdhA (succinate dehydrogenase) and sucA (oxoglutarate dehydrogenase)) are also downregulated in the presence of glucose for W3110. However, not all the genes which are upregulated in the presence of glucose in BW25113 are upregulated in W3110 under the same conditions (examples are aceE (pyruvate dehydrogenase E1 component), guaB (IMP dehydrogenase), rpsQ (30S ribosomal subunit protein S17)). This is likely to be due to differences between these two strains [26,31-33] as well as the differences in experimental methods.
###end p 18
###begin p 19
Summary of genome-wide effects of CRP* expression. 
###end p 19
###begin p 20
Four different conditions were tested: W3110 in LB+glucose medium (WT G), W3110 in LB medium (WT), PC05 in LB+glucose medium (CRP* G), and PC05 in LB medium (CRP*). Differences in gene expression levels with a P-value of <0.05 were considered significant in each comparison.
###end p 20
###begin p 21
Expression levels for the genes discussed in this paper. 
###end p 21
###begin p 22
Four different conditions were tested: W3110 in LB+glucose medium (WT G), W3110 in LB medium (WT), PC05 in LB+glucose medium (CRP* G), and PC05 in LB medium (CRP*)
###end p 22
###begin p 23
Comparison between expression levels (signal values) of the wild-type strain genes in response to the presence of glucose in two different studies. 
###end p 23
###begin p 24
This comparison focuses on genes involved in central metabolism.
###end p 24
###begin p 25
###xml 0 233 0 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genome-wide transcriptional effects of glucose in strain W3110 expressing wild-type CRP, presented as expression ratios for individual genes showing significant differential expression in the presence and absence of glucose (WT G/WT)</bold>
###xml 235 238 235 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 349 352 349 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 412 416 412 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
Genome-wide transcriptional effects of glucose in strain W3110 expressing wild-type CRP, presented as expression ratios for individual genes showing significant differential expression in the presence and absence of glucose (WT G/WT). a) 629 genes show significant changes in expression level in response to the presence of glucose in strain W3110. b) The changes in expression levels of the same genes shown in (a) in CRP* strain PC05, in response to glucose. Gene names and expression levels are given in supplementary Table S2 (see Additional file 2).
###end p 25
###begin p 26
###xml 7 9 7 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
Figure 1b depicts the changes in expression levels of the same genes shown in Figure 1a for CRP mutant strain PC05 in response to glucose. The average WT G/WT ratio for the genes which are upregulated in W3110 in the presence of glucose is 4.06 while the average CRP* G/CRP* ratio for the same genes is 1.07. For downregulated genes in W3110 by glucose, WT G/WT and CRP* G/CRP* ratios are 0.32 and 0.81 respectively. These results show that genes whose expression is significantly altered by glucose in strain W3110 are generally not altered to the same extent in strain PCO5 and that CRP* suppresses this effect of glucose.
###end p 26
###begin p 27
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Figure 2 depicts that fewer genes show significant changes in expression level for strain PC05 (80 genes) compared to W3110 (629 genes) when grown in the presence versus absence of glucose. 29 of these genes are upregulated in the presence of glucose. This confirms the expected role of CRP* in the alleviation of glucose repression. Only 43 genes are common between those of Figure 1 and Figure 2. In contrast to W3110, the number of genes that are repressed in the presence of glucose in PC05 is greater than the number of genes that are upregulated. Only 3% of genes that are upregulated in W3110 in the presence of glucose are also upregulated in PC05 in the same condition, while 12% of glucose-repressed genes in W3110 are also repressed by glucose in PC05.
###end p 27
###begin p 28
###xml 0 216 0 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genome-wide transcriptional effects of glucose in CRP* strain PC05, presented as expression ratios for individual genes showing significant differential expression in the presence and absence of glucose (CRP* G/CRP*)</bold>
###xml 218 221 218 221 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 317 320 317 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 380 384 380 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
Genome-wide transcriptional effects of glucose in CRP* strain PC05, presented as expression ratios for individual genes showing significant differential expression in the presence and absence of glucose (CRP* G/CRP*). a) 80 genes show significant changes in expression level for strain PC05. Only 29 are upregulated. b) The changes in expression levels of the same genes shown in (a) for strain W3110, in response to glucose. Gene names and expression levels are given in supplementary Table S3 (see Additional file 3).
###end p 28
###begin p 29
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ptsG</italic>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">che </italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dhaM </italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edd </italic>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gnt </italic>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt (</italic>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ser </italic>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ymf </italic>
###xml 755 760 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argD </italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glp </italic>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gntP </italic>
###xml 896 901 896 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srlA </italic>
###xml 933 939 933 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thiCE </italic>
###xml 986 992 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">treBC </italic>
###xml 1051 1052 1051 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
The complete list of expression levels of the genes that are differentially expressed between in PC05 with versus without glucose is provided in Supplementary Table S3 (see Additional file 3). Specific examples of genes that are upregulated in PC05 in response to glucose include: the PTS gene ptsG, che genes (involved in regulation of chemotaxis), dhaM (associated with dihydroxyacetone kinase), edd (encoding phosphogluconate dehydratase of the Entner-Doudoroff pathway), gnt genes (gluconate transport and metabolism), genes involved in amino acid metabolism such as glt (glutamate synthase), and ser (serine biosynthesis) genes, and ymf genes of the lambdoid prophage element e14. Genes that are downregulated in PC05 in response to glucose include: argD (involved in lysine and arginine biosynthesis), glp genes (glycerol transport and metabolism), gntP (encoding a gluconate transporter), srlA (glucitol/sorbitol PTS system), thiCE genes (involved in thiamine biosynthesis), and treBC genes (trehalose transport and metabolism). Refer to Table 2 for expression levels and ratios.
###end p 29
###begin p 30
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1567 1568 1567 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 17 24 <span type="species:ncbi:562">E. coli</span>
418 genes in the E. coli genome are suggested to be regulated in part by CRP, as reported by the most current EcoCyc database [34]. While the modes of regulation of many of these genes are complicated and not well understood (often involving multiple transcription factor binding sites), the CRP-cAMP complex is assigned to be a transcriptional activator for approximately 321 genes (implying upregulation in the absence of glucose) and a repressor for approximately 46 genes (implying downregulation in the absence of glucose) (in some cases the role of CRP is dual or unclear). While 629 genes show significant changes in their expression levels in response to the presence of glucose in W3110 (Figure 1), only 19% of them (118 out of 629) have a CRP binding site close to their start codon (these genes are highlighted in green in Additional file 2 (Table S2)). This result is perhaps not unexpected when considering that most genes under CRP control are also regulated by other transcription factors [34]. Of these 118 genes, 25 are upregulated while 93 show reduced expression in the presence of glucose. 77 out of the 93 genes downregulated in glucose are described in Ecocyc as being activated by CRP-cAMP, showing good agreement with the expected inverse relationship between glucose presence and CRP-cAMP activity. Meanwhile only 23 of the 80 genes showing significant differential expression in the presence of glucose for strain PC05 are present among the list of 418 genes believed to be directly regulated by CRP (highlighted in green in Additional file 3 (Table S3); 7 are upregulated in glucose, and 13 out of the remaining 16 downregulated genes are reported to be activated by CRP-cAMP and therefore expected to show lower expression in the presence of glucose), again demonstrating significant alleviation of catabolite repression. Thus, the majority of expression changes resulting from the presence of glucose or the CRP* mutations are not directly related to altered regulation by CRP at CRP binding sites, but rather due to secondary effects resulting from a smaller number of direct, CRP-mediated expression differences.
###end p 30
###begin p 31
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ppsA </italic>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glp </italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mgl </italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fumA </italic>
###xml 672 689 672 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sdhA, sdhB, sdhD </italic>
To investigate which genes respond differently to glucose in PC05 compared to W3110, an interaction term ((CRP* G/CRP*)/(WT G/WT)) was examined with the same criteria as pair-wise comparisons. This comparison reports the difference of differences and reveals that 238 genes respond differently to the presence of glucose in W3110 compared to PC05, as illustrated in Figures 3a and 3b (listed in supplementary Table S4 (see Additional file 4)). As shown in Table 2, ppsA (encoding phosphoenolpyruvate synthase), glp genes (involved in glycerol transport and metabolism), mgl genes of the galactose ABC transporter, and TCA cycle genes fumA (fumarate hydratase class I) and sdhA, sdhB, sdhD (succinate dehydrogenase) all show significantly different responses to glucose in W3110 compared to PC05.
###end p 31
###begin p 32
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genes that respond differently to the presence of glucose in W3110 compared to PC05, (CRP* G/CRP*)/(WT G/WT)</bold>
###xml 110 113 110 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 225 228 225 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 282 286 282 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
Genes that respond differently to the presence of glucose in W3110 compared to PC05, (CRP* G/CRP*)/(WT G/WT). a) Ratio of expression levels of these 238 genes in strain W3110 in the presence and absence of glucose (WT G/WT). b) Ratio of expression levels of the same genes shown in (a) in strain PC05, in the presence and absence of glucose (CRP* G/CRP*). Gene names and expression levels are given in supplementary Table S4 (see Additional file 4).
###end p 32
###begin p 33
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glp </italic>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mgl </italic>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tdc </italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tnaB </italic>
###xml 737 741 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gcd </italic>
###xml 775 780 775 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glnP </italic>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro </italic>
###xml 859 863 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">udp </italic>
Pair-wise comparison between the CRP* G and WT G conditions identifies the changes in transcriptional levels of genes affected by CRP* in the presence of glucose. In this category, 349 genes show significant changes in their expression levels (Table 1), as depicted in Figure 4 and as listed in supplementary Table S5 (see Additional file 5). Many of the genes upregulated by CRP* (strain PC05) are involved in transport, catabolism, and amino acid metabolism (Table 2), including glp genes (involved in glycerol transport and metabolism), mgl genes (galactose ABC transporter), tdc genes (involved in serine and threonine metabolism), and tnaB (encoding a tryptophan transporter). Genes downregulated by CRP* in this comparison include gcd (encoding glucose dehydrogenase), glnP (glutamine ABC transporter), pro genes (involved in proline biosynthesis), and udp (uridine phosphorylase, involved in pyrimidine ribonucleoside metabolism). Additional differentially expressed genes of relevance to this study are described in the Discussion.
###end p 33
###begin p 34
###xml 0 200 0 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Significant genome-wide transcription effects of expressing CRP* (strain PC05) instead of wild-type CRP (W3110) in the presence of glucose, presented as individual gene expression ratios (CRP* G/WT G)</bold>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
Significant genome-wide transcription effects of expressing CRP* (strain PC05) instead of wild-type CRP (W3110) in the presence of glucose, presented as individual gene expression ratios (CRP* G/WT G). 349 genes show significant changes in their expression levels between CRP* G and WT G conditions. Gene names and expression levels are given in supplementary Table S5 (see Additional file 5).
###end p 34
###begin p 35
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gapC </italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrf </italic>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tdc </italic>
Pair-wise comparison of gene expression in PC05 and W3110 grown on LB (without glucose) reveals changes in gene transcription levels as a result of the CRP* mutation. This comparison shows that 553 genes are expressed differently (392 of them are upregulated) between these two strains in the absence of glucose. These results are summarized in Table 1, and the specific genes are listed in supplementary Table S6 (see Additional file 6). gapC (encoding glyceraldehyde 3-phosphate dehydrogenase), nrf genes (involved in anaerobic respiration), and tdc genes (involved in serine and threonine metabolism) are examples of genes upregulated by CRP*.
###end p 35
###begin p 36
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrf </italic>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">citF </italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat </italic>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edd </italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ldhA </italic>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fru </italic>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">manZ </italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ptsG</italic>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">malF </italic>
Finally, to examine the extent to which CRP* reduces the glucose effect, we performed a pair-wise test between two conditions: PC05 in the presence of glucose (CRP* G) and W3110 in the absence of glucose (WT). Our results show that the transcriptional levels of 481 genes are significantly different between these two conditions. These results are summarized in Table 1 and the specific genes and expression values are listed in supplementary Table S7 (see Additional file 7). Examples of genes most significantly upregulated by CRP* in glucose include the nrf genes, citF (encoding citrate lyase), gat genes (involved in hexitol transport and metabolism), edd (encoding phosphogluconate dehydratase), ldhA (lactate dehydrogenase), fru genes (fructose transport and metabolism), manZ (mannose PTS permease), ptsG, and malF (maltose ABC transporter).
###end p 36
###begin title 37
Real-Time Reverse Transcription PCR
###end title 37
###begin p 38
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ppsA </italic>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pntA</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpsQ </italic>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
To confirm the microarray results, the transcript levels of ppsA and pntA, both of which showed significant changes in their transcriptional levels under the various conditions tested, were compared by real-time reverse transcription PCR. The transcript of rpsQ was also analyzed, as this gene was noted to respond quite differently to the presence of glucose with wild-type CRP in our study as compared to the study by Gosset (WT G/WT value of 0.51 compared to 2.7) [30]. Data are presented in supplementary Table S8b as fold-changes (signal ratios) for all conditions tested, and show a good agreement between microarray and real-time RT-PCR results (see Additional file 8).
###end p 38
###begin title 39
Cofactor analysis
###end title 39
###begin p 40
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB </italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 344 353 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;xylB</italic>
###xml 474 482 470 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 532 534 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 564 573 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;xylB</italic>
###xml 634 636 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 474 481 <span type="species:ncbi:562">E. coli</span>
In order to better understand how CRP* expression may influence NADPH availability for xylose reduction, intracellular cofactor concentrations were quantified for wild-type and CRP* strains engineered to produce xylitol. To prevent xylose metabolism in these strains, xylB encoding xylulokinase was deleted [24]. The wild-type CRP strain (W3110DeltaxylB) was transformed with plasmid pPCC207 for inducible co-expression of an NADPH-dependent xylose reductase (CbXR) and the E. coli ATP-dependent xylose transporter system (XylFGH) [25], while the CRP* strain (PC05DeltaxylB) was transformed with plasmid pLOI3815 for CbXR expression [24]. The strains were then compared after growth on glucose (no xylitol production) versus growth on glucose plus xylose (resulting in xylose reduction).
###end p 40
###begin p 41
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 417 419 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 581 583 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 641 643 638 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 666 668 663 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 861 863 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 977 979 974 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1064 1066 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1159 1160 1156 1157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1291 1293 1288 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Results from the intracellular cofactor concentration measurements are summarized in Table 4. Also listed are the xylitol production results for these strains in batch fermentations and resting cell cultures. Note that the CRP* strain produced considerably more xylitol and with a higher yield. In the absence of xylose, the NADPH concentration is significantly higher in the CRP* strain (0.8 versus 0.5 mumol (g cdw)-1). Meanwhile, given the ability to reduce xylose to xylitol, the NADPH concentration falls to a much lower level in the CRP* strain (from 0.8 to 0.1 mumol (g cdw)-1) compared to wild-type CRP (from 0.5 to 0.3 mumol (g cdw)-1). While the NADPH/NADP+ ratios are nearly identical for both strains in the absence of glucose, the significant consumption of NADPH during xylose reduction coincides with a significantly larger drop in the NADPH/NADP+ ratio for CRP* (from 0.09 to 0.01) compared to wild-type CRP (from 0.10 to 0.05). Also note that the oxidized NADP+ concentrations are significantly elevated in the CRP* strain, while both NADH and NAD+ concentrations are much lower. The net effects are higher total NADP(H) (i.e. NADPH plus NADP+) concentrations and lower NAD(H) concentrations in the CRP* strains compared to wild-type. It is also noteworthy that the NADH/NAD+ ratio is significantly lower in the CRP* strain under both conditions tested.
###end p 41
###begin p 42
Culture performance and intracellular cofactor levels and ratios for strains engineered to produce xylitol. 
###end p 42
###begin p 43
###xml 5 15 5 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;xylB </italic>
###xml 78 88 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;xylB </italic>
W3110DeltaxylB harboring plasmid pPCC207 expresses CbXR and XylFGH, while PC05DeltaxylB harboring plasmid pPLOI3815 expresses CbXR. Strains were grown in the presence of glucose only (G) or in glucose plus xylose (GX), enabling xylose reduction during glucose metabolism. Standard deviations were less than 15% unless noted.
###end p 43
###begin p 44
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
a Reported in Table 4 of reference [26].
###end p 44
###begin p 45
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 141 145 141 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
b Resting cells were prepared as described [61]. Values reported were measured after 24 hours of biotransformation with cells suspended to OD600 = 2.0.
###end p 45
###begin p 46
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
c Reported as moles xylitol produced per mole glucose consumed.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
We previously used a CRP* strain to promote expression of xylose transporters in the presence of glucose to produce xylitol from a glucose+xylose mixture, with xylose metabolism disabled [24]. Plasmid-based, CRP-independent expression of xylose transporters in wild-type crp strains was an alternative strategy we explored to enhance xylose uptake and xylitol production in the presence of glucose [25]. However the favorable effects of CRP* expression were found to go beyond improving xylose transport and to include other beneficial phenotypes such as reduced acetate production and higher yields on xylose reduced per mole of glucose consumed (as shown in Table 4) [26].
###end p 48
###begin p 49
Transcription changes associated with CRP* expression are extensive. While many of the genes known to be regulated by CRP show altered expression in the context of CRP*, the majority of differentially expressed genes are not known to be directly under CRP control. The complex network of genes showing altered regulation due to secondary effects of CRP* is not likely to be metabolically systematic, since the mutant CRP used in this study (i.e. CRP*) does not have an evolved physiological role, was isolated under very particular growth conditions, and does not simply serve as a constitutive, cAMP-independent regulator. Therefore the difficulty in identifying clear patterns of differential expression of metabolically related genes is perhaps not surprising (the mutations in CRP* may not uniformly alter the regulator's natural physiological role at different control sites). Rather than attempting to assign physiological meaning to the altered transcriptome, we instead identify gene expression changes that help to explain the beneficial effects of CRP* expression as they relate to xylitol production. Specifically, we focus on genes that may affect NADPH availability.
###end p 49
###begin title 50
Improved cofactor availability for xylitol production
###end title 50
###begin p 51
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 3 10 <span type="species:ncbi:562">E. coli</span>
In E. coli, complete oxidation of glucose during aerobic growth requires that respiration and anabolic metabolism consume reducing equivalents as they are generated [35]. Elevated glucose flux beyond the capacity of respiration and growth results in incomplete oxidation and acid secretion. Heterologous, NADPH-dependent xylitol production can act as an added electron sink in strains producing xylitol from a mixture of glucose and xylose, and an increased ability to produce xylitol during aerobic growth is expected to increase glucose oxidation and tricarboxylic acid (TCA) cycle flux, provided reducing equivalents from NADH can be converted to NADPH. Alternately, increased expression of genes involved in glucose oxidation would allow for increased xylitol production, provided reducing equivalents can be delivered as NADPH. Our transcription analysis sheds light on the observed ability of CRP* strains expressing xylose reductase to produce more xylitol and secrete less acetate than similar wild-type CRP strains constitutively expressing a xylose transporter.
###end p 51
###begin p 52
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sdhA</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sdhB</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sdhD </italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fumA </italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdh </italic>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acs </italic>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 781 786 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sthA </italic>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sthA </italic>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1084 1085 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1087 1092 1087 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sthA </italic>
###xml 1169 1174 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sthA </italic>
###xml 1265 1270 1265 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sthA </italic>
###xml 1565 1570 1565 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pntA </italic>
###xml 1574 1578 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pntB</italic>
###xml 1726 1734 1726 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1770 1772 1770 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1794 1799 1794 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maeB </italic>
###xml 1928 1936 1928 1936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1726 1733 <span type="species:ncbi:562">E. coli</span>
###xml 1928 1935 <span type="species:ncbi:562">E. coli</span>
TCA cycle genes involved in reactions between succinate and oxaloacetate are upregulated in PC05 compared to W3110 in the presence of glucose, as listed in Table 2. These include sdhA, sdhB, sdhD (encoding succinate dehydrogenase), fumA (encoding fumarate hydratase class I), and mdh (encoding malate dehydrogenase). All of these genes are known to have CRP binding sites in their promoter regions, so increased expression in PC05 is likely due to direct regulatory effects of CRP*. A strain with a more active TCA cycle potentially increases glucose oxidation, produces more NADPH and produces less acetate [36,37]. Upregulation of acs (acetyl-CoA synthetase) in CRP* G compared to WT G (3.63-fold) may promote acetate assimilation instead of accumulation. Also shown in Table 2, sthA encoding soluble pyridine nucleotide transhydrogenase is differentially expressed in CRP* G compared to WT G (CRP* G/WT G ratio of 0.6). SthA is believed to primarily oxidize NADPH to regenerate NADH and an increase in NADPH demand corresponds to reduced sthA expression [38,39]. As shown in Table 2, sthA expression is lower with CRP* G compared to WT G. Transcriptional control of sthA is not well understood, but the lack of an apparent CRP binding site suggests that reduced sthA expression may be a result of increased NADPH demand rather than a direct result of CRP*-mediated control. Consistent with this apparent elevated demand for NADPH is the fact that the genes encoding both subunits of the membrane-bound, proton-translocating pyridine nucleotide transhydrogenase (pntA and pntB) are upregulated in CRP* G compared to WT G (1.88 and 1.76-fold respectively). PntAB has been reported to produce 35-45% of the NADPH required for E. coli biosynthesis during aerobic growth [38]. Interestingly, the maeB gene encoding NADP-linked malic enzyme (decarboxylating malate to pyruvate) can serve as another source of NADPH regeneration in E. coli and also shows a higher level of transcription in PC05 compared to W3110 in the presence of glucose (CRP* G/WT G ratio of 2.6). Changes in transcriptional patterns of the above mentioned genes can be in response to increased demands for NADPH in CRP* strains, perhaps as this relates to apparently increased anabolic demands (described below).
###end p 52
###begin p 53
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 889 891 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1056 1058 1052 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 28 35 <span type="species:ncbi:562">E. coli</span>
To ensure continued growth, E. coli balances intracellular concentrations and ratios of the reduced and oxidized cofactors through a complex interplay between catabolic metabolism, anabolic metabolism, redox-sensitive regulation (both genetic and allosteric) and transhydrogenase activities [35,40-43]. While the mechanisms of maintaining redox balance are not well understood, the expression levels of enzymes and regulators involved in redox metabolism play a critical role. It is thus perhaps not surprising that altering the activity of a global regulator has a significant impact on cofactor concentrations and the range of attainable redox states (as demonstrated in Table 4). NADH regulates the activity of a number of enzymes involved in central metabolism and glucose oxidation (e.g. pyruvate dehydrogenase [44,45], citrate synthase [46,47] and alpha-ketoglutarate dehydrogenase [48]). CRP* expression results in reduced NADH levels, increased production of NADPH relative to NADH, and increased tolerance to a range of NADPH levels and NADPH/NADP+ ratios, all of which are likely to improve NADPH-dependent xylitol production during glucose metabolism.
###end p 53
###begin title 54
Expression of "unnecessary" genes
###end title 54
###begin p 55
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tnaA </italic>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thrA </italic>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glyA </italic>
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tdcB </italic>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thrC </italic>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thrB </italic>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asnA </italic>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
Most of the genes that are differentially expressed between PC05 and W3110 in the presence of glucose (231 out of 349) are upregulated with CRP* (Figure 4), supporting the generally assumed behavior of CRP* in alleviating glucose-dependent catabolite repression. The otherwise unnecessary upregulation of these genes likely causes a significant increase in demand for carbon and energy, helping to explain the slower growth rate observed for PC05 compared to W3110 [24]. Notable genes that fall into this upregulated category include many involved in amino acids metabolism, such as tnaA (encoding tryptophanase), thrA (aspartokinase I and homoserine dehydrogenase I), glyA (serine hydroxymethyl transferase), tdcB (threonine dehydratase), thrC (threonine synthase), thrB (homoserine kinase), and asnA (asparagine synthetase A) (refer to Table 2). Upregulation of amino acid metabolism pathways may be in response to increased protein synthesis demands caused by upregulation of other genes.
###end p 55
###begin title 56
Catabolite repression and inducer exclusion
###end title 56
###begin p 57
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 200 204 200 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 320 324 320 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ppsA</italic>
###xml 773 776 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc</sup>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
A relationship between the phosphorylation state of enzyme IIAGlc and the intracellular "phosphoenolpyruvate (PEP)/pyruvate" ratio has been suggested [9]. Decreased levels of phosphorylated enzyme IIAGlc is usually accompanied by decreased PEP/pyruvate ratios. The crucial role of the unphosphorylated form of enzyme IIAGlc in catabolite repression and inducer exclusion is well documented [8,9,14-18]. As shown in Table 2, phosphoenolpyruvate synthase (encoded by ppsA) is expressed to a higher level in PC05 compared to W3110 in the presence of glucose (CRP* G/WT G ratio of 5.35). Upregulation of this enzyme which mediates conversion of pyruvate to PEP may increase the intracellular PEP/pyruvate ratio, resulting in an increase in the phosphorylated form of enzyme IIAGlc. This in turn may increase adenylate cyclase activity [17,18] and further help to alleviate catabolite repression and inducer exclusion in PC05.
###end p 57
###begin title 58
Conclusion
###end title 58
###begin p 59
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 66 73 <span type="species:ncbi:562">E. coli</span>
We have used microarray analysis to compare the transcriptomes of E. coli W3110 expressing wild-type CRP and mutant strain PC05 expressing CRP* in the presence and absence of glucose. Table 1 summarizes the genome-wide effects of CRP* expression under the conditions tested. Gene expression in the context of CRP* in the presence of glucose is very different from that of wild-type in the absence of glucose. Although fewer genes show expression sensitivity to glucose in PC05 compared to W3110, CRP* does not completely eliminate glucose effects. As expected, CRP* expression causes increased expression of genes involved in nutrient transport and catabolism (among many others). In addition, several genes showing significant differential expression in CRP* versus wild-type CRP help to explain the observed differences in cofactor levels and metabolic behavior of CRP* strains used in xylitol production.
###end p 59
###begin title 60
Materials and methods
###end title 60
###begin title 61
General
###end title 61
###begin p 62
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp*</italic>
###xml 268 272 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB</italic>
###xml 294 298 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB</italic>
###xml 327 329 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 345 350 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp* </italic>
###xml 359 364 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB </italic>
###xml 459 463 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp*</italic>
###xml 472 473 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 497 501 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB</italic>
###xml 507 510 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aac</italic>
###xml 517 519 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 565 568 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp</italic>
###xml 594 598 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB</italic>
###xml 738 754 722 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida boidinii</italic>
###xml 787 791 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tac </italic>
###xml 854 856 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 884 891 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylFGH </italic>
###xml 0 12 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 142 147 <span type="species:ncbi:4932">yeast</span>
###xml 738 754 <span type="species:ncbi:5477">Candida boidinii</span>
E. coli K-12 strain W3110 (ATCC 27325) and its derivatives were maintained on plates containing Luria-Bertani (LB) medium (10 g tryptone, 5 g yeast extract, 5 g NaCl, and 15 g agar per liter). Methods for construction of strains PC05 (W3110 and crp*), PC07 (W3110DeltaxylB), and PC09 (PC05DeltaxylB) were described previously [24]. Briefly, the crp* gene and xylB deletion were introduced into W3110 via P1 phage transduction using a lysate from strain ET25 (crp*::Tn10) [8] and PC06 (W3110, DeltaxylB::FRT-aac-FRT) [24] followed by selections on tetracycline (for crp*) or apramycin (for DeltaxylB) plates. Plasmid pLOI3815 is a medium copy, pBR322-origin vector carrying a kanamycin resistance marker and the xylose reductase gene from Candida boidinii, which is located downstream of tac promoter and upstream of a transcription termination sequence [24]. Xylose transporter genes xylFGH (ATP-dependent xylose transporter system) were cloned downstream of CbXR in pLOI3815 to make plasmid pPCC207.
###end p 62
###begin p 63
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp* </italic>
###xml 130 132 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 618 623 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp* </italic>
###xml 744 746 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Amino acid substitutions in the CRP* were confirmed by sequencing. The crp* phenotype was verified in two ways. First, several TetR transductants were grown in LB medium containing glucose (1%) and xylose (1%). Cells were harvested at mid logarithmic growth phase and washed twice in phosphate buffer containing kanamycin (50 mug/mL). After allowing time for residual sugars to be cleared, the cells were resuspended a final time in buffer containing xylose (1%), kanamycin, and 1% triphenyltetrazolium chloride (TTC). Reduction of TTC results in red color formation and indicates constitutive xylose utilization. The crp* phenotype was additionally confirmed using HPLC to verify simultaneous glucose and xylose consumption in batch cultures [24].
###end p 63
###begin title 64
Growth conditions
###end title 64
###begin p 65
###xml 357 360 357 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 385 389 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">384 </sup>
###xml 684 688 684 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 847 851 841 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 907 911 901 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 1071 1075 1059 1063 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
Four different conditions were tested in this study: W3110 in LB medium (WT), W3110 in LB+glucose medium (WT G), PC05 in LB medium (CRP*), and PC05 in LB+glucose medium (CRP* G). All experiments were performed at least in triplicate and all data reported are the average of at least three experiments. Cell culture optical density was measured at 600 nm (OD600) using a SPECTRAMax PLUS384 spectrophotometer (Molecular Devices). Cells grown for harvesting were prepared briefly as follows. Overnight pre-seed cultures were prepared by inoculating 3 ml of LB medium (in 13 x 100 mm tube) with a few colonies from a fresh LB plate. The overnight cultures were used to inoculate, to an OD600 of 0.1, 50 ml LB media (with or without 0.4% glucose supplementation) seed cultures in a 250 ml shake-flask. The seed culture were grown at 37degreesC to an OD600 of ~2 and then were used to directly inoculate, to an OD600 of 0.02, 100 ml LB media (with or without 0.4% glucose supplementation) cultures in a 500 ml flask. These cultures were grown at 37degreesC and 250 rpm to an OD600 of 0.5.
###end p 65
###begin title 66
Cell harvesting and preparation of RNA
###end title 66
###begin p 67
###xml 53 57 53 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
Cells from the 100 ml culture were harvested at an OD600 of 0.5 (early logarithmic growth phase) by immediately placing on ice, transferring to 50 ml falcon tubes and centrifuging at 4degreesC for 5 minutes before treating with lysozyme. Promega PureYieldtrade markRNA Midiprep System kit was used for RNA extraction. As a preliminary check, RNA yield and quality were determined by spectrophotometry according to the manufacturer's protocol and the integrity of the purified RNA was determined by formaldehyde agarose gel electrophoresis.
###end p 67
###begin title 68
Labeling, hybridization and scanning
###end title 68
###begin p 69
###xml 782 790 781 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 892 900 885 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 947 949 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 782 789 <span type="species:ncbi:562">E. coli</span>
###xml 892 899 <span type="species:ncbi:562">E. coli</span>
Total RNA concentration and purity were determined using a NanoDrop spectrophotometer and total RNA integrity was examined using an Agilent Bioanalyzer. Total RNA of sufficient concentration, purity, and integrity was labeled and subsequently hybridized to Affymetrix GeneChip microarrays by the Penn State DNA Microarray Facility according to the manufacturer's instructions (Affymetrix Inc, Santa Clara, CA). Briefly, 10 mug of total RNA was converted to cDNA using random primed reverse transcription. cDNA was purified by removing the RNA via hydrolysis with NaOH and then neutralizing the solution. Purified cDNA was fragmented and subsequently end-labeled with biotin. Fragmented, end-labeled cDNA was dissolved in hybridization cocktail and hybridized to Affymetrix GeneChip E. coli Genome 2.0 Arrays (approximately 10000 probe set) for 16 hours at 45degreesC. The details of GeneChip E. coli Genome 2.0 Arrays are described by Affymetrix [49].
###end p 69
###begin p 70
After hybridization, the hybridization cocktail was removed and the arrays were washed to remove unbound and non-specifically bound cDNA. Hybridization was detected by staining the arrays with streptavidin phycoerythrin. All washing and staining was performed using the Affymetrix GeneChip Fluidics Station 450 according to the manufacturer's instructions (Affymetrix Inc, Santa Clara, CA). Stained arrays were scanned using the Affymetrix GCS3000 7G scanner.
###end p 70
###begin title 71
Microarray data analysis
###end title 71
###begin p 72
###xml 630 638 621 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 709 717 700 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 630 637 <span type="species:ncbi:562">E. coli</span>
###xml 709 721 <span type="species:ncbi:83333">E. coli K-12</span>
A minimum of three data sets was generated for each of the four different conditions tested (based on the combination of the strains W3110 and PC05 in LB and LB+glucose media). Affymetrix Expression Consoletrade marksoftware (Version 1.1) was used for background adjustment, normalization and summarization of chip level data in the form of feature intensity (CEL) files in order to generate probe set summarization (CHP) files, using the probe logarithmic intensity error (PLIER) method. Data from CHP files were then exported to a Microsoft Excel spreadsheet for further analysis. Signal values for 10208 probsets from GeneChip E. coli Genome 2.0 Arrays were filtered to extract probe set data for only the E. coli K-12 strain. All calculations and analyses were performed on the 4070 genes remaining after filtration.
###end p 72
###begin p 73
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 726 734 726 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 856 857 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 726 738 <span type="species:ncbi:83333">E. coli K-12</span>
Signal values were transformed to the log base for the pair-wise comparisons. A linear model was fitted to each gene using the Bioconductor software package LIMMA [50,51] in the R environment [52]. The linear model coefficients were used to calculate significant differences in expression levels for all pair-wise comparisons. The P-values were adjusted by the Benjamini-Hochberg method [53] and genes with a P-value of <0.05 were considered as those with significantly different expression levels under different conditions tested. Data are reported as expression levels (signal values) or ratios of expression levels. Supplementary Table S1 (Additional file 1) contains signal values for the complete probe set data for the E. coli K-12 genome. Written code in R [52] (file name: sup_code.doc) can be found in supplementary material (see Additional file 9). Gene Annotations were transformed from AFFY probe set ID's to Entrez gene IDs using NETAFFX on the Affymetrix website [49]. The online database for annotation, visualization and integrated discovery (DAVID) [54,55] and Kyoto Encyclopedia of Genes and Genome (KEGG) [56] were used for pathway visualization and gene ontology (GO) classification.
###end p 73
###begin title 74
Real-time, Reverse Transcription PCR
###end title 74
###begin p 75
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ppsA </italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pntA </italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpsQ </italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rrsH </italic>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 908 912 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 949 953 947 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1019 1021 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
Total RNA samples were isolated the same way as for microarray studies. ppsA (phosphoenolpyruvate synthase), pntA (membrane-bound proton-translocating pyridine nucleotide transhydrogenase), and rpsQ (30S ribosomal subunit protein S17) were selected for confirmation by real-time reverse transcription PCR with rrsH (encoding 16S ribosomal RNA) as a control. Primer and probe sequences used for RT-PCR are listed in supplementary Table S8a (Additional file 8) and were designed by Deborah S. Grove of the Penn State Nucleic Acid Facility using Primer Express v2.0 (Applied Biosystems, Foster City, CA). Probes were synthesized by Biosearch (Novato, CA). The Applied Biosystems High Capacity cDNA Reverse Transcription Kit (part number 4368813) was used for reverse transcription according to the manufacturer's instructions for cDNA production. cDNA was amplified in an ABI 7300 real-time machine using TaqMan(R) Universal PCR Master Mix, No AmpErase(R) UNG (part number 4324018). Output was analyzed using the  method [57].
###end p 75
###begin title 76
Cofactor measurements
###end title 76
###begin p 77
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 337 342 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB </italic>
###xml 382 387 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xylB </italic>
###xml 453 457 439 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 513 517 499 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 830 834 808 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 958 962 930 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
The cofactor analysis used in this study is based on the methods developed by Bernofsky and Swan [58], and modified by Gibon and Larher [59], and Walton and Stewart [60]. To investigate the effect of xylitol production on intracellular NADP(H) and NAD(H) levels, cofactor concentrations and ratios were measured and compared in PC05DeltaxylB strain harboring pLOI3815 and W3110DeltaxylB harboring pPCC207. Seed cultures were grown at 37degreesC to an OD600 of ~2 and then were used to directly inoculate, to an OD600 of 0.02, 100 ml LB medium supplemented with 100 mM glucose, 100 mM xylose (or 200 mM glucose for non-xylitol producing conditions), 50 mM MOPS, kanamycin monosulfate (50 mug/ml) and isopropyl-B-D-thiogalactopyranoside (IPTG, 100 muM) in a 500 ml flask. These cultures were grown at 30degreesC and 250 rpm to an OD600 of 0.5. Cells were immediately chilled on ice and harvested by pelleting (4degreesC, 15 min, 3750 rpm) to achieve a final OD600 of 30 in 1 ml. To isolate the oxidized forms, the pellet was resuspended in 0.5 ml of 0.3 M HCl, 50 mM Tricine-NaOH (pH 8.0). To isolate the reduced forms, the pellet was resuspended in 0.5 ml of 0.3 M NaOH. All samples were then heated to 60degreesC for 7 minutes followed by a neutralization step (0.5 ml 0.3 M NaOH for oxidized forms, 0.3 ml 0.3 M HCl, 0.2 ml 1.0 M Tricine-NaOH (pH 8.0) for reduced forms). The neutralized solutions were then centrifuged (4degreesC, 60 min, 13000 rpm) and the supernatants were transferred to a new microcentrifuge tube.
###end p 77
###begin p 78
###xml 782 786 773 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">384 </sup>
Cofactor levels were measured in a 96-well microtiter plate. Either 40 mul of oxidized sample and 40 mul 0.1 M NaCl, or 80 mul of reduced sample was aliquoted to a single well. The 2X stock solution of the reaction mixture consisted of equal volumes of 1.0 M Tricine-NaOH (pH 8.0), 4.2 mM MTT, 40 mM EDTA, 1.67 mM PES, and substrate (either 5 M ethanol or 25 mM glucose-6-phosphate). After addition of the appropriate reaction mixture (ethanol for NAD(H), glucose-6-phosphate for NADP(H)), the plate was incubated at 37degreesC for 5 minutes. To start the reaction, either 10 units/ml alcohol dehydrogenase (from 100 units/ml stock) or 0.27 units/ml glucose-6-phosphate dehydrogenase (from 2.7 units/ml stock) was added. The formation of reduced MTT was monitored using a SpectraMax384 plate reader, taking readings every 15 seconds for 10 minutes using a wavelength of 570 nm while being incubated at 37degreesC. The cofactor concentration of the samples was interpolated by comparing the rate of reaction to that observed in a concentration curve run on the same plate, and subtracting the rate from the background of the sample (reaction without enzyme).
###end p 78
###begin title 79
Competing interests
###end title 79
###begin p 80
The authors declare that they have no competing interests.
###end p 80
###begin title 81
Authors' contributions
###end title 81
###begin p 82
RK and JWC performed the experiments, DG assisted in experimental design and data analysis, RK and PCC wrote the manuscript. All authors have read and approved the final manuscript.
###end p 82
###begin title 83
Note
###end title 83
###begin p 84
**NOTE: Average signal values start at column Q in Table S1 and at column D in Tables S2-S7. Expression ratios start at column H in Tables S2-S7.
###end p 84
###begin title 85
Supplementary Material
###end title 85
###begin title 86
Additional file 1
###end title 86
###begin p 87
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 64 76 <span type="species:ncbi:83333">E. coli K-12</span>
Table S1. Signal values for the complete probe set data for the E. coli K-12 genome.
###end p 87
###begin p 88
Click here for file
###end p 88
###begin title 89
Additional file 2
###end title 89
###begin p 90
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Table S2. Expression levels of the genes that are differentially expressed between WT G and WT conditions (presented in Figure 1). Genes highlighted in green have a CRP binding site close to their start codon.
###end p 90
###begin p 91
Click here for file
###end p 91
###begin title 92
Additional file 3
###end title 92
###begin p 93
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Table S3. Expression levels of the genes that are differentially expressed between CRP* G and CRP* conditions (presented in Figure 2). Genes highlighted in green have a CRP binding site close to their start codon.
###end p 93
###begin p 94
Click here for file
###end p 94
###begin title 95
Additional file 4
###end title 95
###begin p 96
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Table S4. Expression levels of the genes that respond differently to the presence of glucose in W3110 compared to PC05, (CRP* G/CRP*)/(WT G/WT) (presented in Figure 3).
###end p 96
###begin p 97
Click here for file
###end p 97
###begin title 98
Additional file 5
###end title 98
###begin p 99
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
Table S5. Expression levels of the genes that are differentially expressed between CRP* G and WT G conditions (presented in Figure 4).
###end p 99
###begin p 100
Click here for file
###end p 100
###begin title 101
Additional file 6
###end title 101
###begin p 102
Table S6. Expression levels of the genes that are differentially expressed between CRP* and WT conditions.
###end p 102
###begin p 103
Click here for file
###end p 103
###begin title 104
Additional file 7
###end title 104
###begin p 105
Table S7. Expression levels of the genes that are differentially expressed between CRP* G and WT conditions.
###end p 105
###begin p 106
Click here for file
###end p 106
###begin title 107
Additional file 8
###end title 107
###begin p 108
Table S8. a) Primer and probe sequences used for RT-PCR. b) Comparison between microarray and real-time reverse transcription PCR results. Data are presented as fold changes (signal ratio) for all conditions tested.
###end p 108
###begin p 109
Click here for file
###end p 109
###begin title 110
Additional file 9
###end title 110
###begin p 111
The file entitled "sup_code.doc" contains the written code in R, used for data analysis.
###end p 111
###begin p 112
Click here for file
###end p 112
###begin title 113
Acknowledgements
###end title 113
###begin p 114
We acknowledge W. Boos (University of Konstanz) for providing strain ET25, Dr. Craig Praul at the Penn State DNA Microarray Facility for assistance with all microarray methods and Dr. Deborah S. Grove of the Penn State Nucleic Acid Facility for assistance with RT-PCR. This research was made possible by a grant from the NSF (BES0519516) and support from the Penn State Associate Vice President for Research
###end p 114
###begin article-title 115
###xml 16 37 16 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli crp </italic>
###xml 16 32 <span type="species:ncbi:562">Escherichia coli</span>
Deletion of the Escherichia coli crp gene
###end article-title 115
###begin article-title 116
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 31 38 <span type="species:ncbi:562">E. coli</span>
Cyclic AMP receptor protein of E. coli: its role in synthesis of inducible enzymes
###end article-title 116
###begin article-title 117
###xml 90 106 90 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 90 106 <span type="species:ncbi:562">Escherichia coli</span>
Relief of catabolite repression in a cAMP-independent catabolite gene activator mutant of Escherichia coli
###end article-title 117
###begin article-title 118
###xml 43 64 43 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli lac </italic>
###xml 43 59 <span type="species:ncbi:562">Escherichia coli</span>
Role of CRP in transcription activation at Escherichia coli lac promoter: CRP is dispensable after the formation of open complex
###end article-title 118
###begin article-title 119
###xml 125 141 125 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 125 141 <span type="species:ncbi:562">Escherichia coli</span>
Cyclic AMP-dependent catabolite repression is the dominant control mechanism of metabolic fluxes under glucose limitation in Escherichia coli
###end article-title 119
###begin article-title 120
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Crr </sup>
###xml 98 115 98 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 98 119 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Correlation between growth rates, EIIACrr phosphorylation, and intracellular cyclic AMP levels in Escherichia coli K-12
###end article-title 120
###begin article-title 121
The bacterial phosphotransferase system: new frontiers 30 years later
###end article-title 121
###begin article-title 122
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">malT </italic>
###xml 52 69 52 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 52 68 <span type="species:ncbi:562">Escherichia coli</span>
Glycerol-3-phosphate-mediated repression of malT in Escherichia coli does not require metabolism, depends on enzyme IIAGlc and is mediated by cAMP levels
###end article-title 122
###begin article-title 123
###xml 21 38 21 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 21 37 <span type="species:ncbi:562">Escherichia coli</span>
Inducer exclusion in Escherichia coli by non-PTS substrates: The role of the PEP to pyruvate ratio in determining the phosphorylation state of enzyme IIA
###end article-title 123
###begin article-title 124
Role of cyclic AMP in bacteria
###end article-title 124
###begin article-title 125
Transcriptional regulation by cAMP and its receptor protein
###end article-title 125
###begin article-title 126
Cyclic AMP in prokaryotes
###end article-title 126
###begin article-title 127
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
Glucose lowers CRP* levels resulting in repression of the lac operon in cells lacking
###end article-title 127
###begin article-title 128
Regulation of lactose permease activity by the phosphoenolpyruvate:sugar phosphotransferase system:Evidence for direct binding of the glucose-specific enzyme III to the lactose permease
###end article-title 128
###begin article-title 129
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Glc </sup>
###xml 165 181 165 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 165 181 <span type="species:ncbi:562">Escherichia coli</span>
The mechanism of inducer exclusion. Direct interaction between purified IIIGlc of the phosphoenolpyruvate:sugar phosphotransferase system and the lactose carrier of Escherichia coli
###end article-title 129
###begin article-title 130
Protein phosphorylation and allosteric control of inducer exclusion and catabolite repression by the bacterial phosphoenolpyruvate: sugar phosphotransferase system
###end article-title 130
###begin article-title 131
###xml 60 77 60 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 60 80 <span type="species:ncbi:83333">Escherichia coli K12</span>
Purification and characterization of adenylate cyclase from Escherichia coli K12
###end article-title 131
###begin article-title 132
###xml 47 63 47 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
A dual mechanism for regulating cAMP levels in Escherichia coli
###end article-title 132
###begin article-title 133
###xml 37 54 37 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
Isolation and characterization of an Escherichia coli mutant affected in the regulation of adenylate cyclase
###end article-title 133
###begin article-title 134
###xml 126 142 126 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 126 142 <span type="species:ncbi:562">Escherichia coli</span>
The cyclic 3',5'-adenosine monophosphate receptor protein and regulation of cyclic 3',5'-adenosine monophosphate synthesis in Escherichia coli
###end article-title 134
###begin article-title 135
Structure-function analysis of 3 cAMP-independent forms of the cAMP receptor protein
###end article-title 135
###begin article-title 136
###xml 71 87 71 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
Mutations that alter the allosteric nature of cAMP receptor protein of Escherichia coli
###end article-title 136
###begin article-title 137
Metabolic engineering applications to renewable resource utilization
###end article-title 137
###begin article-title 138
###xml 12 29 12 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 12 28 <span type="species:ncbi:562">Escherichia coli</span>
Engineering Escherichia coli for xylitol production from glucose-xylose mixtures
###end article-title 138
###begin article-title 139
###xml 66 82 66 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 66 82 <span type="species:ncbi:562">Escherichia coli</span>
Role of xylose transporters in xylitol production from engineered Escherichia coli
###end article-title 139
###begin article-title 140
###xml 19 36 19 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 19 40 <span type="species:ncbi:83333">Escherichia coli K-12</span>
###xml 80 89 <span type="species:ncbi:37762">E. coli B</span>
Comparison between Escherichia coli K-12 strains W3110 and MG1655 and wild-type E. coli B as platforms for xylitol production
###end article-title 140
###begin article-title 141
Thermodynamics of cyclic nucleotide binding to the cAMP receptor protein and its T127L mutant
###end article-title 141
###begin article-title 142
###xml 50 66 50 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
Mutagenesis of the cyclic AMP receptor protein of Escherichia coli:targeting positions 72 and 82 of the cyclic nucleotide binding pocket
###end article-title 142
###begin article-title 143
Sites of allosteric shift in the structure of the cyclic-amp receptor protein
###end article-title 143
###begin article-title 144
###xml 81 97 81 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 81 97 <span type="species:ncbi:562">Escherichia coli</span>
Transcriptome analysis of CRP-dependent catabolite control of gene expression in Escherichia coli
###end article-title 144
###begin article-title 145
###xml 143 160 143 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 143 164 <span type="species:ncbi:83333">Escherichia coli K-12</span>
The plasticity of global proteome and genome expression analyzed in closely related W3110 and MG1655 strains of a well-studied model organism, Escherichia coli K-12
###end article-title 145
###begin article-title 146
###xml 16 33 16 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 16 37 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection
###end article-title 146
###begin article-title 147
###xml 36 53 36 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 36 57 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110
###end article-title 147
###begin article-title 148
###xml 32 49 32 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
EcoCyc: A comprehensive view of Escherichia coli biology
###end article-title 148
###begin article-title 149
Different biochemical mechanisms ensure network-wide balancing of reducing equivalents in microbial metabolism
###end article-title 149
###begin article-title 150
The acetate switch
###end article-title 150
###begin article-title 151
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 104 113 <span type="species:ncbi:37762">E. coli B</span>
###xml 125 132 <span type="species:ncbi:562">E. coli</span>
Transcription levels of key metabolic genes are the cause for different glucose utilization pathways in E. coli B (BL21) and E. coli K (JM109)
###end article-title 151
###begin article-title 152
###xml 112 128 112 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 112 128 <span type="species:ncbi:562">Escherichia coli</span>
The soluble and membrane-bound transhydrogenases UdhA and PntAB have divergent functions in NADPH metabolism of Escherichia coli
###end article-title 152
###begin article-title 153
###xml 65 82 65 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 65 81 <span type="species:ncbi:562">Escherichia coli</span>
Metabolic flux response to phosphoglucose isomerase knock-out in Escherichia coli and impact of overexpression of the soluble transhydrogenase UdhA
###end article-title 153
###begin article-title 154
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 136 143 <span type="species:ncbi:562">E. coli</span>
The organization of the membrane domain and its interaction with the NADP(H)-binding site in proton-translocating transhydrogenase from E. coli
###end article-title 154
###begin article-title 155
Physiological functions of thioredoxin and thioredoxin reductase
###end article-title 155
###begin article-title 156
###xml 72 88 72 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 72 88 <span type="species:ncbi:562">Escherichia coli</span>
Understanding and harnessing the microaerobic metabolism of glycerol in Escherichia coli
###end article-title 156
###begin article-title 157
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">udhA </italic>
###xml 17 34 17 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 17 33 <span type="species:ncbi:562">Escherichia coli</span>
The udhA gene of Escherichia coli encodes a soluble pyridine nucleotide transhydrogenase
###end article-title 157
###begin article-title 158
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
Regulation of pyruvate dehydrogenase from Escherichia coli. Interactions of adenylate energy charge and other regulatory parameters
###end article-title 158
###begin article-title 159
###xml 105 122 105 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 105 126 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Dihydrolipoamide dehydrogenase mutation alters the NADH sensitivity of pyruvate dehydrogenase complex of Escherichia coli K-12
###end article-title 159
###begin article-title 160
Comparative analysis of folding and substrate binding sites between regulated hexameric type II citrate synthases and unregulated dimeric type I enzymes
###end article-title 160
###begin article-title 161
Insights into the evolution of allosteric properties. The NADH binding site of hexameric type II citrate synthases
###end article-title 161
###begin article-title 162
###xml 37 53 37 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
2-oxoacid dehydrogenase complexes of Escherichia coli: cellular amounts and patterns of synthesis
###end article-title 162
###begin article-title 163
Affymetrix
###end article-title 163
###begin article-title 164
Limma: Linear models for microarray data
###end article-title 164
###begin article-title 165
Linear models and empirical Bayes methods for assessing differential expression in microarray experiments
###end article-title 165
###begin article-title 166
R
###end article-title 166
###begin article-title 167
Controlling the False Discovery Rate: a practical and powerful approach to multiple testing
###end article-title 167
###begin article-title 168
DAVID: Database for Annotation, Visualization, and Integrated Discovery
###end article-title 168
###begin article-title 169
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
###end article-title 169
###begin article-title 170
The KEGG resource for deciphering the genome
###end article-title 170
###begin article-title 171
Analysis of relative gene expression data using real-time quantitative PCR and the  method
###end article-title 171
###begin article-title 172
An improved cycling assay for nicotinamide adenine dinucleotide
###end article-title 172
###begin article-title 173
Cycling assay for nicotinamide adenine dinucleotides: Nacl precipitation and ethanol solubilization of the reduced tetrazolium
###end article-title 173
###begin article-title 174
###xml 68 85 68 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 68 84 <span type="species:ncbi:562">Escherichia coli</span>
Understanding and improving NADPH-dependent reactions by nongrowing Escherichia coli cells
###end article-title 174
###begin article-title 175
###xml 65 81 <span type="species:ncbi:562">Escherichia coli</span>
Analysis of NADPH supply during xylitol production by engineered Escherichia coli
###end article-title 175

